The Tumor Blueprint, created by the Clearity Foundation scientific team, is based on the results from the biomarker tests. These results are interpreted in the context of information derived from our review of clinical research and information from previously tested patients in the Diane Barton Database.
Clearity will work with each patient and her physician to review the results and discuss which therapeutic options are most likely to be effective, based on the molecular profile. We will also provide information about clinical trials that may be appropriate.
